Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0410
+0.0020
+(5.13%)
As of 1:32:49 PM GMT+1. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
Verrico (Christopher) Director of Issuer | Acquisition or disposition in the public market | Mar 11, 2024 | 1,574,539 |
Verrico (Howard Jarman) Director of Issuer | Stock dividend | Oct 21, 2024 | 10,455,695 |
Related Tickers
IPH.PA Innate Pharma S.A.
2.1250
-3.63%
ACRV Acrivon Therapeutics, Inc.
5.39
+0.94%
QTTB Q32 Bio Inc.
2.2300
-0.45%
IOBT IO Biotech, Inc.
0.9600
-3.93%
ZYME Zymeworks Inc.
13.48
+1.01%
UCB.BR UCB SA
181.55
+0.72%
SRRK Scholar Rock Holding Corporation
37.43
+4.09%
PLRX Pliant Therapeutics, Inc.
3.1600
-3.07%
PRME Prime Medicine, Inc.
2.4800
+2.48%
SGMT Sagimet Biosciences Inc.
3.6600
+1.39%